Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden · Delayed Price · Currency is SEK 64.30
-0.50 (-0.77%)
Nov 4, 2026, 5:29 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 1.09 billion as of November 4, 2026. It is the 24,196th most valuable company in the world and the 300th biggest in Sweden. Its market cap has decreased by 46.98% in one year.
Market Cap
1.09B
Enterprise Value
1.05B
Revenue
253.60M
Global Rank
Country Rank
#300 Sweden
PE Ratio
42.79
ChartMarket Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has decreased from 1.35B to 1.09B, a decrease of -19.66%. That is a compound annual growth rate of -4.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 1.09B | -42.90% |
| Dec 30, 2025 | 1.90B | -2.79% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
| Dec 10, 2021 | 1.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BICO Group AB | 1.73B |
| Paxman AB | 1.54B |
| Sedana Medical AB | 926.81M |
| C-Rad AB | 783.39M |
| Episurf Medical AB | 630.62M |
| Bactiguard Holding AB | 560.70M |
| Senzime AB | 532.17M |
| Ortoma AB | 456.17M |